New ACP guidance suggests starting mammograms at 50 instead of 40 for average-risk women, one every two years, sparking debate among breast cancer screening experts.

Should screening for BRCA1/2 mutations be expanded to all women diagnosed with breast cancer? This is the recommendation put forth in recent guidelines from the American Society of Clinical Oncology ...

This study analyzes BRCA testing patterns in U.S. breast cancer patients, highlighting barriers and disparities in access to genetic testing and precision care.

"It feels irresponsible," an oncologist told Newsweek.

Updated guidance from the ACP recommends that women 50 to 74 receive mammograms every 2 years. However, other organizations ...

Genetics is always changing. It seems as if every day there is a new article about a new study, and trying to navigate all of this information can be quite confusing. This past month, a new study was ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

More women are requesting BRCA gene testing associated with certain types of cancer thanks to increased interest in the procedure. Traditionally women tested for mutations in the cancer-susceptibility ...

From left: Dr Allan Njau, Consultant Anatomic and Molecular Pathologist, Dr Affrin Shaffi, and Dr Njoki Njiraini during the AstraZeneca BRCA testing launch in Nairobi, November 28, 2025. [Ryan Kerubo, ...